Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Protocol biopsies after kidney transplantation.

Georg A Böhmig1, Heinz Regele, Walter H Hörl

  • 1Division of Nephrology and Dialysis, Department of Internal Medicine III, University of Vienna, Vienna, Austria. georg.boehmig@nephro.imed3.akh-wien.ac.at

Transplant International : Official Journal of the European Society for Organ Transplantation
|February 5, 2005
PubMed
Summary

Kidney transplant biopsies reveal high rates of subclinical rejection and chronic nephropathy. Treating subclinical rejection may improve long-term outcomes, highlighting the clinical relevance of protocol biopsies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Highly sensitized kidney transplant candidates: integrating acceptable mismatch, desensitization, imlifidase, and emerging immune-cell targeting strategies.

Frontiers in immunology·2026
Same author

Viewpoint on donor-derived cell-free DNA: context of use and clinical utility are key.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2026
Same author

The Role of Natural Killer Cells in Kidney Transplantation.

Transplantation·2026
Same author

Donor bone marrow together with recipient regulatory T cells induces chimerism without irradiation in kidney transplantation.

Science translational medicine·2026
Same author

Impact of high-altitude exposure on Torque Teno virus and immunosuppression levels in lung transplantation recipients: climbing Mount Jebel Toubkal.

Scientific reports·2026
Same author

Clazakizumab in the treatment of chronic active antibody-mediated kidney transplant rejection: Results from the IMAGINE phase 3, randomized, double-blind, placebo-controlled study.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2026

Area of Science:

  • Nephrology
  • Transplantation Immunology
  • Pathology

Background:

  • Protocol biopsies in stable kidney transplants frequently show subclinical acute rejection (SAR) and chronic allograft nephropathy (CAN).
  • Both SAR and CAN are associated with poorer long-term kidney allograft survival.
  • Early detection and treatment of SAR may improve graft outcomes.

Purpose of the Study:

  • To review the potential benefits and risks of performing protocol kidney allograft biopsies in stable transplant recipients.
  • To discuss the clinical significance of findings from protocol biopsies, including SAR and CAN.
  • To evaluate the impact of SAR treatment on long-term allograft outcomes.

Main Methods:

  • Review of existing literature on protocol biopsies in kidney transplantation.

Related Experiment Videos

  • Analysis of studies investigating the prevalence and impact of subclinical findings.
  • Discussion of randomized prospective studies on SAR treatment.

    • Main Results:

    • High prevalence of subclinical acute rejection and chronic allograft nephropathy in early protocol biopsies.
    • Established association between SAR/CAN and long-term allograft failure.
    • Evidence suggests improved allograft outcomes following treatment of SAR.

    Conclusions:

    • Protocol kidney allograft biopsy is clinically relevant for detecting subclinical injury.
    • Timely intervention for subclinical acute rejection may enhance long-term graft survival.
    • Careful consideration of benefits and risks is essential for stable kidney transplant recipients undergoing biopsy.